Has a moderately strong antihypertensive effect and can reduce peripheral resistance

For patients with high blood pressure and chronic cardiac insufficiency, it can improve heart pumping function, increase cardiac output, reduce the occurrence of arrhythmias, and reduce mortality.

Hypertension accompanied by diabetes: reduce glomerular permeability to protein, improve nephropathy in insulin-dependent diabetes, reduce urinary protein, and improve renal function

First-line drug for antihypertensive treatment, suitable for all types of hypertension

Suitable for patients with diabetes and insulin resistance

Hypertensive patients with left ventricular hypertrophy, heart failure, and acute myocardial infarction

Dry cough, elevated blood potassium

lower blood pressure

Reduce heart load

Inhibit extracellular calcium ion influx

Effective for mild, moderate and severe hypertension

anti-angina pectoris

Improve cardiac hypertrophic heart disease

Treating Raynaud's disease and preventing atherosclerosis

Increased heart rate, facial flushing, dizziness, headache, etc.

Hypertensive patients after acute myocardial infarction should not use it

Blocks cardiac β1 adrenergic receptors and reduces cardiac output

Blocks β1 adrenergic receptors in cells next to renal afferent arterioles and reduces renin secretion

Blocks central β-adrenergic receptors and reduces peripheral sympathetic nerve activity

Blocks the presynaptic membrane β2 adrenergic receptors in peripheral noradrenergic nerve terminals, inhibits positive feedback regulation, reduces the release of NA, and promotes the synthesis of PGI2

clinical application

adverse reactions